Form 8-K - Current report:
SEC Accession No. 0001104659-26-051692
Filing Date
2026-04-29
Accepted
2026-04-29 17:07:22
Documents
12
Period of Report
2026-04-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2611405d14_8k.htm   iXBRL 8-K 25426
2 EXHIBIT 99.1 tm2611405d14_ex99-1.htm EX-99.1 12434
  Complete submission text file 0001104659-26-051692.txt   208001

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20260429.xsd EX-101.SCH 3020
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20260429_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20260429_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2611405d14_8k_htm.xml XML 3219
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 26917810
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)